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Pathogenesis of hypertension in a mouse model for
human CLCN2 related hyperaldosteronism
Corinna Göppner1,2,8, Ian J. Orozco1,2,8, Maja B. Hoegg-Beiler1,2, Audrey H. Soria 1,2, Christian A. Hübner3,
Fabio L. Fernandes-Rosa4,5, Sheerazed Boulkroun 4,5, Maria-Christina Zennaro4,5,6 & Thomas J. Jentsch 1,2,7
Human primary aldosteronism (PA) can be caused by mutations in several ion channel genes
but mouse models replicating this condition are lacking. We now show that almost all known
PA-associated CLCN2 mutations markedly increase ClC-2 chloride currents and generate
knock-in mice expressing a constitutively open ClC-2 Cl− channel as mouse model for PA.
The Clcn2op allele strongly increases the chloride conductance of zona glomerulosa cells,
provoking a strong depolarization and increasing cytoplasmic Ca2+ concentration. Clcn2op
mice display typical features of human PA, including high serum aldosterone in the presence
of low renin activity, marked hypertension and hypokalemia. These symptoms are more
pronounced in homozygous Clcn2op/op than in heterozygous Clcn2+/op mice. This difference
is attributed to the unexpected finding that only ~50 % of Clcn2+/op zona glomerulosa cells
are depolarized. By reproducing essential features of human PA, Clcn2op mice are a valuable
model to study the pathological mechanisms underlying this disease.
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W ith an estimated prevalence of about 5–10% inhypertensive patients, the most common cause ofsecondary arterial hypertension is primary aldoster-
onism (PA)1,2. Aldosterone is synthesized from the precursor
cholesterol in zona glomerulosa (ZG) cells in the adrenal cortex in
an enzymatic cascade that involves aldosterone synthase
(CYP11B2) as the final step1,3. Aldosterone production is nor-
mally tightly regulated by angiotensin II, extracellular K+ con-
centration, and ACTH, but is also influenced by other factors1,3.
Acute stimulation of aldosterone synthesis involves phosphor-
ylation of StAR. It enhances the transport of cholesterol into
mitochondria where it is converted to pregnenolone, a precursor
for both aldosterone and cortisol in humans or corticosterone in
rodents (both synthesized in the adrenal zona fasciculata (ZF)).
Medium- to long-term stimulation of aldosterone production is
achieved by transcriptional upregulation of aldosterone synthase
which is specifically expressed in ZG cells. Being hydrophobic,
aldosterone leaves the cell by diffusing across the plasma mem-
brane. Aldosterone exerts its effect on blood pressure (BP) pri-
marily by stimulating Na+ reabsorption in the distal renal tubule
through the Na+ channel ENaC. Via electrostatic coupling,
increased Na+ absorption augments distal tubular K+- and H+-
secretion4. Besides kidney, aldosterone acts on several other target
organs1,5.
PA is caused by autonomous aldosterone production in the
adrenal cortex1. It is associated with arterial hypertension, low
plasma levels of renin, the regulatory enzyme that cleaves the
angiotensin precursor angiotensinogen, and often with low serum
concentration of K+. The high serum aldosterone in patients with
PA causes tissue damage in the cardiovascular system and kidney
in excess of that caused by high BP alone1,6–9.
PA has a strong genetic component. Both somatic mutations in
aldosterone-producing adenomas and germ-line mutations in
Mendelian forms of the disease have been found. The majority of
genes mutated in PA encode ion channels and transport
ATPases10,11. A rise in the cytoplasmic Ca2+ concentration
([Ca2+]i) is the most common mechanism by which such
mutations stimulate aldosterone production. An increase in
[Ca2+]i can be a direct consequence of gain-of-function muta-
tions in the Ca2+ channel genes CACNA1D12,13 and
CACNA1H14,15, encoding α-subunits of L-type and T-type Ca2+
channels, respectively, or of loss-of-function mutations in
ATP2B3 (ref. 16) that encodes the Ca2+-extruding plasma
membrane ATPase PMCA3. Mutations in other ion-transporting
proteins increase [Ca2+]i indirectly by depolarizing ZG cells to
voltages that open voltage-gated Ca2+-channels. These include
mutations in ATP1A1 (refs. 13,16), coding for the α1-subunit of
the Na+,K+-ATPase, and mutations in KCNJ5 (ref. 17) encoding
the Kir3.4 (GIRK4) K+ channel. Gain-of-function KCNJ5 muta-
tions typically cause depolarizing Na+ influx by changing the
channel’s selectivity filter17. In mice, disruption of both Kcnk3
and Kcnk9, encoding the “two pore” K+ channels TASK1 and
TASK3, respectively, elicits symptoms resembling PA18–21. These
two “background” K+ channels mediate a large part of the resting
conductance that keeps ZG cell plasma membranes hyperpolar-
ized. Most recently, we22 and others23 reported that gain-of-
function mutations in the CLCN2 gene, which encodes the Cl−
channel ClC-2, underlie early-onset or familial forms of PA.
ClC-2 is a plasma membrane chloride channel that belongs to
the CLC family of Cl− channels and transporters24,25. ClC-2 is
widely expressed across mammalian tissues26. It is only partially
open under resting conditions and slowly activates upon hyper-
polarization26. It is also activated by cell swelling27 and mildly
acidic extracellular pH28. Our laboratory previously mapped
structures important for these modes of activation to a ~45
residue-long stretch of the ClC-2 amino-terminus27 and to an
intracellular loop between intramembrane helices J and K28.
Deletions or mutations in these “inactivation” or “gating-mod-
ulating” regions abolish the voltage-, pH-, and swelling-sensitivity
of ClC-2 and strongly increase current amplitudes. In glia, ClC-2
associates with the cell adhesion molecule GlialCAM which
directs ClC-2 to certain cell−cell contacts and “opens” ClC-2
similar to mutations in the “inactivation” domains29,30.
Several physiological roles of ClC-2 became apparent from the
analysis of ClC-2 knock-out (KO) mice (Clcn2−/− mice) and
human inherited disease. Clcn2−/− mice display early postnatal
testicular and retinal degeneration31 and slowly progressive
leukodystrophy30,32. These pathologies were attributed to
impaired extracellular ion homeostasis30–32. Patients with CLCN2
loss-of-function mutations likewise display leukodystrophy33 that
is sometimes associated with impaired vision and reduced male
fertility34. Reduced colonic Cl− reabsorption in Clcn2−/− mice
additionally indicates a role in transepithelial transport35,36.
Here we find that almost all known PA-associated CLCN2
mutations markedly increase ClC-2 Cl− currents. The only
exception likely represents a silent polymorphism. To test the
hypothesis that an increase in ClC-2 currents suffices to cause PA,
we generate knock-in mice carrying a Clcn2 mutation (Clcn2op)
that is not found in human PA, but increases ClC-2 currents to a
similar degree as the majority of PA-causing human mutations.
ZG cells of Clcn2op mice are depolarized by this gain-of-function
mutant to an extent that was amply sufficient to open voltage-
gated Ca2+ channels. The resulting increase in intracellular Ca2+
concentration enhances transcription of aldosterone synthase,
increases serum aldosterone levels, and causes hypertension,
hypokalemia, and mild renal abnormalities. Adrenal cortex-
specific disruption of the Clcn2op allele indicates that its effect on
aldosterone is ZG cell-intrinsic. Thus, Clcn2op mice reproduce the
clinical and biochemical features of human PA.
Results
PA-associated CLCN2 mutations increase Cl− currents. Until
now, six different mutations affecting the ClC-2 Cl− channel26
have been identified in patients with PA22,23 (Fig. 1a). Three
mutations, p.Met22Lys (M22K), p.Gly24Asp (G24D), p.Tyr26Asn
(Y26N) affect residues in a short segment of the ClC-2 amino-
terminus. p.Arg172Gln (R172Q) changes an amino acid at the
cytoplasmic end of helix D. p.Lys362Δ (ΔK362) deletes a lysine at
the end of the cytoplasmic loop between helices J and K and
Ser865Arg (S865R) alters a residue close to the end of the
carboxy-terminus. Intriguingly, the N-terminal mutations fall
into a highly conserved region we had identified previously as
being crucial for channel gating27, and K362 localizes to the end
of a cytoplasmic loop that similarly affects gating28. Deletions and
missense mutations in either region strongly “open” the ClC-2
channel when expressed in Xenopus oocytes. Instead of being
slowly activated by inside-negative voltages, cell swelling, or
acidic extracellular pH (pHo), mutant channels are insensitive to
these stimuli and current amplitudes are increased more than 10-
fold at physiological voltages27,28. This suggests that these four
mutations identified in PA may strongly increase ClC-2 currents.
Indeed, we previously reported a striking increase in ClC-2
currents with the G24D mutant, both in two-electrode voltage
clamp (TEVC) of Xenopus oocytes and in perforated-patch
measurements of transfected H295R-S2 adrenocortical cells22. No
comparable data are available for the mutations described by
Scholl et al.23 who analyzed these mutations using whole-cell
patch clamping of transfected cells. However, this procedure,
possibly by dialyzing the cell interior, almost completely abolishes
the large increase of ClC-2 currents caused by N-terminal
mutations25,37,38. Accordingly Scholl et al.23 detected only modest
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changes in gating and have probably overlooked the physiologi-
cally relevant effects.
We now evaluated all described PA-related CLCN2
mutations22,23 under appropriate conditions in both Xenopus
oocytes (Fig. 1b–n) and HEK cells (Supplementary Fig. 1b–h).
We compared the results to those obtained with a previously
described “open” deletion mutant that removes residues
Y32TQELGAF from the N-terminus of rodent ClC-2 (ref. 27).
Since rodent Y32 corresponds to human Y26, this deletion
eliminates the residue changed in the Y26N mutant23.
When measured by TEVC in Xenopus ooyctes, all four human
mutations in either gating-modulating region27,28 (M22K, G24D/
G30D in rodent, Y26N, and ΔK362) increased ClC-2 currents by
an order of magnitude and abolished the strong voltage-
dependence of wild-type (WT) ClC-2 (Fig. 1b–e, h, k–n).
Currents from these mutants and the N-terminal rodent deletion
construct (op) were indistinguishable. By contrast, currents from
the R172Q ClC-2 mutant were more moderately increased (~4-
fold; Fig. 1f, m, n). Unlike G24D22 and other N-terminal and J-K
loop mutants28, R172Q partially retained voltage-dependent
gating and responded to changes in pHo (Fig. 1g). The
carboxy-terminal S865R variant23 lacked discernable effects on
ClC-2 currents (Fig. 1i, m, n), suggesting that it represents a silent
polymorphism.
Similar results were obtained with HEK cells when using the
perforated patch-clamp technique that minimizes changes in the
composition of the cytoplasm (Supplementary Fig. 1a–h). Again,
mutations in either “gating-modifying” region increased current
amplitudes about 10-fold and almost completely abolished gating
(Supplementary Fig. 1b, c, e–h). Current amplitudes in HEK cells
displayed a larger scatter probably because of a variable
transfection efficiency compared to well-controlled cRNA injec-
tion into oocytes (Supplementary Fig. 1h, Fig. 1n). The difference
in current amplitudes between mutations in the “gating-
modifying” regions and the R172Q mutant was less pronounced
than in the oocyte system (Supplementary Fig. 1d, g, h).
Knock-in mice expressing “open ClC-2”. With the exception of
S865R that probably does not cause disease, all PA-associated
CLCN2 mutations strongly increased ClC-2 currents. We there-
fore predicted that any other mutation strongly enhancing Cl−
currents is able to cause PA. To test this hypothesis, we generated
knock-in mice expressing an “open” ClC-2 mutant (op) that has
not been found in human disease, but opens ClC-2 to the same
degree as human mutations (Supplementary Fig. 2a–c). We chose
to introduce a well-characterized ablation of eight N-terminal
residues (YTQELGAF)27. This deletion “opens” ClC-2 equiva-
lently as several other deletions in the N-terminus27 or the J-K
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Fig. 1 Characterization of human Clcn2 gene variants in primary aldosteronism and the op allele. a ClC-2 topology model, based on the CLC crystal
structure66, mapping positions of genetic variants found in early-onset primary aldosteronism22,23. N-terminal and J-K linker domains previously
shown27,28 to be important for opening ClC-2 are highlighted in red. b–l Representative current traces obtained by two-electrode voltage clamp of Xenopus
oocytes injected with the indicated ClC-2 cRNAs. Voltage clamp protocol indicated in the inset of panel b. The rodent “op” mutant exactly mimics the
channel encoded by the Clcn2op allele in the present knock-in mouse model. For comparison to the human G24D mutant, the equivalent G30D rodent
mutant was measured. In some experiments (f, g) individual ClC-2(R172Q)-expressing oocytes (n= 7) were first measured with ND109, pH 7.4 and then
in ND109 buffered to pH 8.5.m Plot of mean current measured at 2 s after clamping to indicated voltages and (n) individual currents at a clamp of −80mV
for experiments of b–l. The number of cells measured is indicated in parenthesis. m, n Currents are presented as mean ± SEM
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linker28 and to the same extent as disease-causing human M22K,
G24D, Y26N, and ΔK362 mutations (Fig. 1c–e, h, l–n, Supple-
mentary Fig. 1b, c, e–h). Hence its effect on Cl− currents is
representative for most known PA-causing human mutations,
with the exception of R172Q that has weaker effects (Fig. 1f, m, n,
Supplementary Fig. 1d, g, h). We flanked protein-encoding exons
2 and 3 with loxP sites to allow for Cre-recombinase-mediated
ablation of the gain-of-function allele in selected tissues (Sup-
plementary Fig. 2a).
Homozygous mice (termed Clcn2op/op mice, “op” for “open”)
were viable and lacked immediately visible phenotypes. Western
blot analysis revealed expression of WT and mutant ClC-2op in
brain, cerebellum, distal colon, and adrenal gland (Supplementary
Fig. 2d), with levels of mutant ClC-2op and WT protein being
comparable in most organs. To exclude that the N-terminal
deletion alters the subcellular distribution of ClC-2, we examined
the colon which expresses comparatively high levels of ClC-2
(Supplementary Fig. 2d). In this tissue, the channel localizes
prominently to basolateral membranes of epithelial cells39. No
differences in ClC-2 expression and localization between WT and
Clcn2op/op mice were detected in KO-controlled immunohisto-
chemistry (IHC) (Supplementary Fig. 3a). This suggests that the
deleted amino-terminal residues do not interact with proteins
involved in ClC-2 protein trafficking and localization.
Western blots of whole adrenal glands indicated a moderate,
~20% decrease of ClC-2 levels in heterozygous Clcn2+/op and
homozygous Clcn2op/op mice compared to WT (Fig. 2a, b).
Agreeing with the wide expression pattern of ClC-2 (ref. 26), KO-
controlled IHC revealed that ClC-2 is expressed both in the ZG
and ZF of the adrenal gland (Fig. 2c), contrasting with previous
results using an antibody of unknown specificity23. In females,
ClC-2 showed particularly high expression in the inner part of the
ZF. Although our previous22 and present (see below) patch-clamp
analysis of ZG cells in situ showed that ClC-2 mediates plasma
membrane currents, ClC-2 expression at the plasma membrane of
ZG cells was under the detection limit of IHC. Rather ClC-2 was
mainly found in the trans-Golgi network (TGN) (Supplementary
Fig. 3b). Likewise, colon epithelial cells, which prominently
express ClC-2 at the plasma membrane, also retained a portion of
ClC-2 in the TGN (Supplementary Fig. 3a). The significance of
this finding is unclear.
Unlike ClC-2, the chloride-accumulating Na+K+2Cl− cotran-
sporter NKCC1 was rather specifically and strongly expressed in
the ZG where it localized to plasma membranes (Fig. 2d). Hence
opening of ClC-2 is predicted to result in a strongly depolarizing
Cl− efflux in ZG, but probably not in ZF cells.
ZG cells expressing the Clcn2op allele are depolarized. To
determine the effect of genetically opening ClC-2 on electrical
parameters of ZG cells in tissue slices, we used the amphotericin-
perforated patch-clamp technique. Chloride currents in WT ZG
cells were barely detectable and much smaller than those we
measured previously in the whole-cell mode22 (Fig. 3a–c). ZG
cells from Clcn2op/op mice, however, had significantly increased
Cl− currents that showed little gating (Fig. 3a–c), as expected
from heterologous expression in HEK cells (Supplementary
Fig. 1f). In Clcn2+/op mice, roughly half of the cells measured
showed very little current like in WT, while the rest showed
robust currents similar to Clcn2op/op mice (Fig. 3a–c).
The resting potential of ZG cells was determined with
gramicidin-perforated patch-clamp recordings to leave native
intracellular chloride concentrations undisturbed. Agreeing
with previous studies3,40,41 and their large resting K+ conduc-
tance42–44, WT ZG cells had a resting potential Vm around −90
mV that is close to the potassium equilibrium potential (Fig. 3d).
By contrast, cells from Clcn2op/op mice were strongly depolarized
to roughly −40 mV. ZG cells from Clcn2+/op mice, modeling
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Fig. 2 Expression of wild type and open ClC-2 protein in mouse adrenal glands. a Representative western blot for ClC-2 of membrane fractions isolated
from adrenal gland tissue of male and female Clcn2+/+ (+/+), Clcn2+/op (+/op), Clcn2op/op (op/op) mice. Antibody specificity was verified with Clcn2−/−
(−/−) adrenal tissue. Equal amounts of protein were loaded, with β-actin serving as a loading control. b Densitometric quantification of protein bands to
determine ClC-2 expression in the adrenal gland of male (blue) and female (red) Clcn2+/op (squares; n= 3 animals) and Clcn2op/op (triangles; n= 6
animals) mice compared to WT (n= 6 animals) assigned a reference value of 1. Short and long bars designate mean ± SEM. c Representative
immunofluorescent staining of ClC-2 in the adrenal cortex of male and female +/+, +/op, and control −/− mice. Twelve-week-old mice were used (a–c).
d Na+K+2Cl− cotransporter (NKCC1) staining in the adrenal cortex of a WT (+/+) mouse, with Nkcc1−/− (−/−) tissue as control (both females and
3 weeks old). c, d White arrowheads indicate approximate boundaries of zona glomerulosa (ZG) and zona fasciculata (ZF). Scale bar, 50 µm (c, d)
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patients who display heterozygous CLCN2 mutations, showed a
large scatter of intracellular potentials (Fig. 3d). The distribution
of Vm appeared bimodal, with about half of the cells displaying
WT voltages and the others being strongly depolarized like in
Clcn2op/op mice. Several cells were superfused with angiotensin II
in perforated-patch recordings with current set to zero. This
elicited depolarization in WT cells (Fig. 3e), but very little to none
in the already strongly depolarized Clcn2op/op cells (Fig. 3h).
Again, there were two distinct cell populations in Clcn2+/op mice,
with one group resembling WT (Fig. 3f) and the other Clcn2op/op
cells (Fig. 3g). Since depolarization may enhance aldosterone
production by raising [Ca2+]i through voltage-gated Ca2+-chan-
nels, these findings predict that serum aldosterone in hetero-
zygous Clcn2+/op mice may reach roughly 50% of the levels
observed in homozygous Clcn2op/op mice.
Altered calcium signaling in Clcn2op/op ZG cells. Ca2+-imaging
of adrenal gland slices using ratiometric Fura-2 fluorescence
revealed that basal [Ca2+]i was increased in Clcn2op/op and Clcn2
+/op ZG cells over WT levels (Fig. 4a–c, Supplementary Fig. 4).
Whereas WT ZG cells lacked obvious spontaneous oscillations of
[Ca2+]i (Fig. 4d, Supplementary Video 1), 62% of ZG cells from
Clcn2op/op mice showed marked Ca2+-oscillations (defined by
amplitudes >0.01 a.u.) that resembled those observed in Task3−/−
mice18 (Fig. 4f, Supplementary Video 2). Heterozygous Clcn2+/op
mice displayed a lower proportion of cells with Ca2+-oscillations
(33% of cells), with some cells starting to show Ca2+ transients
during recordings (Fig. 4e, middle trace). Ca2+ oscillations could
be induced in WT ZG cells by angiotensin II (Fig. 4g). The
increase in cytosolic [Ca2+] observed in Clcn2op mice is expected
to increase the transcription of Cyp11b2 encoding aldosterone
synthase3.
Aldosterone synthase transcription in Clcn2op/op mice. We
used quantitative reverse transcription polymerase chain reaction
(qRT-PCR) to assess the expression of key enzymes of adrenal
steroidogenesis, Star (encoding the steroidogenic acute regulatory
protein), Cyp21a1 (encoding steroid 21-hydroxylase, like StAR
involved in both aldosterone and corticosterone synthesis path-
ways), Cyp11b2 (encoding aldosterone synthase), and Cyp11b1
(encoding 11β-hydroxylase responsible for the final step of cor-
ticosterone synthesis) (Fig. 5a–d). No significant differences
between WT, Clcn2+/op, and Clcn2op/op genotypes were observed
for Star and Cyp21a1 transcript levels (Fig. 5a, b). By contrast,
significant increases in Cyp11b2 transcripts were observed in both
male and female Clcn2op/op mice, with heterozygous Clcn2+/op
mice showing a tendency for an increase (Fig. 5c). Levels of
Cyp11b1 did not differ between genotypes (Fig. 5d), suggesting
that the opening of ClC-2 channels, although expressed in both
ZG and ZF (Fig. 2c), specifically stimulates aldosterone produc-
tion. IHC of adrenal gland sections revealed an increased number
of aldosterone synthase-positive cells in the ZG of Clcn2op/op
mice (Fig. 5e, f). Hematoxylin-eosin staining and IHC for the ZG
cell marker Dab2 (ref. 45) did not reveal major morphological
changes of adrenal glands, such as ZG area (Supplementary
Figs. 5 and 6). No adenomas were detected in male or female
Clcn2op/op mice up to an age of 52 weeks.
Aldosterone levels in homo- and heterozygous Clcn2op mice.
Aldosterone levels and renin activity were determined in serum of
WT, Clcn2+/op, and Clcn2op/op mice of both genders (Fig. 6).
Serum aldosterone was increased in Clcn2op/op mice by more
than 10-fold and to a lesser degree in Clcn2+/op mice (Fig. 6a). As
typical for PA, renin activity was strongly suppressed in homo-
zygous, and to a lesser extent in heterozygous, Clcn2op mice
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Fig. 3 Increased chloride current and membrane depolarization in Clcn2op zona glomerulosa cells. a Representative traces of chloride currents in ZG cells
from Clcn2+/+ (7 cells, 7 mice), Clcn2+/op (9 cells, 8 mice), Clcn2op/op (6 cells from 6 mice) adrenal slices, designated as +/+, +/op, and op/op, and
measured with amphotericin-perforated patch clamp using the voltage step protocol shown in inset. b Plot of mean ± SEM currents measured at the end of
voltage steps (1.5 s) as a function of voltage from experiments performed in a. The number of cells measured is indicated in parenthesis. c Individual
current values of a, b at a clamp voltage of −80mV. d Individual ZG cell membrane potentials Vm from Clcn2op mouse models using gramicidin-perforated
patches with I=0 (9 +/+ cells from 9 mice, 18 +/op cells from 12 mice, 10 op/op cells from 8 mice) that leave intracellular chloride undisturbed. Long and
short bars represent means ± SEM, respectively. Since Vm distribution of +/op cells appears bimodal, no mean value is shown. d–g Voltage traces of +/+,
+/op, op/op cells (representative of 2, 7, and 5 cells, respectively) that were superfused with 100 nM angiotensin II (Ang II) indicated by a thick line
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(Fig. 6b). Corticosterone levels were unchanged (Fig. 6c). In
accord with markedly increased aldosterone levels, Clcn2op/op
mice displayed hypokalemia (Table 1).
We additionally compared serum and urine aldosterone levels,
as well as serum renin activity and corticosterone levels, between
WT and Clcn2op/op mice under low- and high-potassium diets
(Supplementary Fig. 7). As expected, aldosterone was increased
with high-potassium diet in WT mice (Supplementary Fig. 7a). In
Clcn2op/op mice, aldosterone levels were increased, and renin
activity decreased, under both low- and high-potassium diets
(Supplementary Fig. 7a, b). Low-potassium diet appeared to
slightly blunt the increase of aldosterone levels in male Clcn2op/op
mice, suggesting that physiological regulatory mechanisms of
aldosterone production were not completely abolished. Corticos-
terone levels were unchanged (Supplementary Fig. 7c).
Although our data provide overwhelming evidence for PA in
Clcn2op/op mice, the regulation of aldosterone biosynthesis
involves feedback mechanisms from several tissues and ClC-2 is
widely expressed26. We therefore wanted to ascertain that the
effect of the Clcn2op allele on aldosterone biosynthesis is ZG cell-
intrinsic. We crossed Clcn2op/op mice (in which exons 2 and 3 of
the Clcn2op allele are floxed) with SF1-Cre mice that express the
recombinase specifically in the adrenal cortex, somatic gonad
cells, and a few other tissues46,47. IHC confirmed the absence of
ClC-2 from the adrenal cortex of these mice (Supplementary
Fig. 8a). Whereas aldosterone levels were strongly increased in
Clcn2op/op mice (Fig. 6a), they were undistinguishable from WT
in SF1-Cre; Clcn2op/op mice (Supplementary Fig. 8c). Moreover,
adrenal Cyp11b2 levels (Supplementary Fig. 8b) and serum renin
activity (Supplementary Fig. 8d) were similar to WT. Hence,
mutant ClC-2op increased aldosterone production in a ZG cell-
intrinsic manner. Moreover, the loss of ClC-2 in ZG cells of SF1-
Cre; Clcn2op/op mice did not lower aldosterone below WT levels.
Open ClC-2 mutant increases BP. Telemetry was used to com-
pare systolic and diastolic BP and heart rate between WT, Clcn2
+/op, and Clcn2op/op mice (Fig. 7, Supplementary Fig. 9). Under
control diet, systolic BP was markedly elevated in male (by ~20
mm Hg) and to a slightly more moderate degree in female Clcn2op/
op mice (Fig. 7a). Systolic BP of heterozygous mice was inter-
mediate between WT and Clcn2op/op mice. No obvious changes in
diastolic BP were detected (Fig. 7b). These measurements were
repeated with the same mice exposed to diets containing high
Na+- or K+-concentrations, or low amounts of K+ (Supplemen-
tary Fig. 9). Again, systolic BP was increased in male Clcn2op/op
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Fig. 4 Increased intracellular calcium in Clcn2op zona glomerulosa cells. a, b Representative images of Clcn2+/+ (a) and Clcn2op/op (b) male adrenal Fura-2
AM-loaded slices. Colors indicate Ca2+ fluorescence under basal conditions. Scale bar, 10 µm. c Quantification of Ca2+ fluorescence from Clcn2+/+ (+/+,
circles), Clcn2+/op (+/op, squares), and Clcn2op/op (op/op, triangles) adrenal gland slices. For each genotype, six mice were analyzed. Single values
represent mean values of cells measured during 2min from one mouse. Error bars, mean ± SEM. ***p < 0.001, +/op and op/op each compared to +/+,
Kruskal–Wallis test with Dunn’s multiple comparison test. d–f Representative Clcn2+/+ (d), Clcn2+/op (e), and Clcn2op/op (f) traces of three individual ZG
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mice, with heterozygous Clcn2+/op appearing to have less than half
of the BP increase and females showing less effect (Supplementary
Fig. 9a). There were no marked changes in diastolic BP with the
exception of female mice under high-Na+ diet (Supplementary
Fig. 9b). Marked changes in heart rate were only observed with
Clcn2op/op mice fed low-K+ diet (Supplementary Fig. 9c).
Serum electrolytes and renal function in Clcn2op mice.
Clcn2op/op mice displayed hypokalemia (Table 1), a frequent
abnormality in PA patients including several of those with
CLCN2 mutations22,23. Hypokalemia results from the stimulatory
effect of aldosterone on distal tubular K+-secretion that serves to
electrically compensate for increased Na+-reabsorption through
aldosterone-regulated ENaC channels. Under low-K+ diet we
additionally observed hypochloremic metabolic alkalosis (low
serum Cl− and more alkaline pH) (Supplementary Table 1). It is
probably caused by increased renal tubular H+ secretion, which is
needed for the electric compensation of increased Na+ reab-
sorption particularly when charge compensation by K+ currents
is reduced by severe hypokalemia4. The resulting increase in
plasma HCO3− anions is compensated by a reduction of Cl−
anions (Supplementary Table 1).
In PA, high aldosterone levels, together with high BP, can lead
to renal damage that may result in albuminuria1,6,8,9,48. Whereas
we did not find obvious signs of renal damage in standard
histology, Clcn2op/op mice displayed moderate albuminuria
(Supplementary Fig. 10). It compared favorably to that of Clcn5
knock-out mice which display impaired proximal tubular
endocytosis49. However, unlike Clcn5 knock-out mice, Clcn2op/op
mice did not display urinary loss of vitamin D-binding protein
(DBP) or retinol-binding protein (RBP), both of which are lost
into the urine upon proximal tubular dysfunction49. Hence
albuminuria of Clcn2op/op mice likely resulted from increased
glomerular filtration. Although end organ damage was not
explored further, this observation suggests that Clcn2op/op mice
might prove useful to investigate secondary tissue damage in PA.
Discussion
Mutations in several genes encoding ion channels of ZG cells
cause human PA10,11,50. Progress in understanding the
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Table 1 Blood electrolyte concentrations and pH of WT, Clcn2+/op, and Clcn2op/op mice
Sex Genotype n Na+ K+ Cl− pH HCO−3
m Clcn2+/+ 8 149.1 ± 0.6 3.6 ± 0.2 114.4 ± 2.1 7.25 ± 0.04 22.2 ± 2.1
m Clcn2+/op 12 150.2 ± 1.2 3.7 ± 1.0 115.3 ± 2.1 7.25 ± 0.05 20.8 ± 2.7
m Clcn2op/op 11 150.6 ± 1.5* 2.9 ± 0.3**** 112.2 ± 3.0 7.29 ± 0.05 22.9 ± 2.4
f Clcn2+/+ 8 149.1 ± 1.0 3.4 ± 0.3 114.1 ± 2.5 7.27 ± 0.04 20.9 ± 1.8
f Clcn2+/op 11 149.5 ± 2.2 3.0 ± 0.3 114.7 ± 2.7 7.27 ± 0.04 21.9 ± 1.5
f Clcn2op/op 10 150.4 ± 1.8 2.6 ± 0.2*** 114.3 ± 1.6 7.27 ± 0.04 21.4 ± 1.6
m male, f female. Ion concentrations in mM. n, number of mice. Significant difference with reference to Clcn2+/+: *p < 0.05, ***p < 0.001, **** p < 0.0001; Mean values ± SD; Kruskal–Wallis test, Dunn’s
multiple comparison test
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underlying pathological mechanisms has been hampered by the
absence of mouse models that faithfully replicate the human
disease51. Here we describe mouse models for the recently
identified CLCN2-related form of human PA22,23. These mice
display high aldosterone and low renin levels, marked hyper-
tension, hypokalemia, and signs of incipient kidney damage.
Clcn2op mice constitute the best mouse model for PA available to
date. The Clcn2op allele, which encodes, like other PA-causing
CLCN2 mutants, an “open” plasma membrane Cl− channel,
increased aldosterone production by ZG cells in a cell-
autonomous manner. Opening of ClC-2 strongly depolarized
native ZG cells, increased [Ca2+]i, and stimulated transcription of
aldosterone synthase-encoding Cyp11b2. Surprisingly, in hetero-
zygous Clcn2+/op mice roughly half of the ZG cells were as
strongly depolarized as in homozygous Clcn2op/op mice, whereas
the other half displayed WT voltages. Consequently, the increases
in aldosterone levels and BP were less pronounced in hetero-
zygous than in homozygous Clcn2op mice. The effect of the
artificial “opening” mutation in our Clcn2op mice strongly sug-
gests that also the human PA-causing CLCN2 mutations, all of
which open ClC-2, cause disease by their increased chloride
currents rather than by other mechanisms. It further suggests that
mutations increasing other Cl− currents in ZG cells may also
provoke aldosteronism.
Consistent with our analysis of the PA-associated mutant p.
Gly24Asp22 we now found that most missense mutants described
by others23 also markedly increased ClC-2 currents. The only
exception is S865R, which was found in a single patient and
which likely is a silent polymorphism. The largest effects were
observed with mutations in previously identified “inactivation” or
“gating-modulating” domains in the cytosolic N-terminus27 and
the J-K linker28. In our previous structure–function studies we
found that the resulting “open” mutants displayed >10-fold
increased current amplitudes and had lost voltage-dependent
gating. Those “open” mutants that were tested had also lost their
activation by cell swelling or moderately acidic pH27,28. Some
mutants displayed an “intermediate” phenotype as defined by
more moderately increased current amplitudes, reduced, but not
abolished gating, and intact pH dependence. Whereas the
mutants in the “gating-modulating” regions (M22K, G24D,
Y26N, ΔK362) resulted in “open” ClC-2 channels, the R172Q
mutant rather showed an “intermediate” effect characterized by
less strongly increased current amplitudes, persistent voltage-
dependent gating, and pH dependence27,28. Intriguingly, only this
mutation was found in several families. It led to dominantly
inherited hyperaldosteronism in three generations of the same
family, but was also found in only mildly affected or even unaf-
fected individuals23. The more frequent observation of this less
severe mutation might result from an increased probability of
inheritance.
The mechanism by which the two previously identified
regions27,28 modulate gating remains obscure. The gating of an
“open” N-terminal deletion mutant could be rescued by trans-
planting the deleted segment into the ClC-2 C-terminus27. This
position-independence suggests that this segment binds either to
the channel, with the J-K loop being a candidate binding site, or
to an associated protein and thereby partially closes the
channel27,28. When this binding is lost or weakened with dele-
tions or point mutations, channels show an “open” phenotype.
The situation is even more complex. It later emerged that the
“opening” effect of N-terminal mutants was largely lost in whole-
cell or excised-patch experiments in which the mutants only
displayed moderately changed gating25,37,38. The mutational
“opening” of ClC-2 thus required an almost intact cytoplasm as
preserved in TEVC of Xenopus oocytes or in perforated-patch-
clamp measurements of transfected mammalian cells. This
suggests that a so-far unknown, diffusible cytoplasmic factor is
necessary for the full manifestation of the “open” phenotype. By
using TEVC of oocytes and perforated-patch recordings of HEK
cells we now revealed the full potential of the mutations described
by Scholl et al.23. The observation that WT ClC-2 currents could
be detected in previous whole-cell measurements22, but not with
perforated-patch recordings of ZG cells in situ (Fig. 3a), and that
they were neither observed in perforated-patch recordings of WT
ClC-2 transfected H295R-S2 cells22, also points to the importance
of an intact cell interior.
The depolarization of ZG cells is obviously not linearly related
to the magnitude of an additional Cl− conductance (such as that
mediated by ClC-2op) because Vm can maximally reach the Cl−
equilibrium potential. Therefore, even if Clcn2+/op cells express
only half the amount of open ClC-2op channels compared to
Clcn2op/op cells, they might be depolarized to (almost) the same
degree as Clcn2op/op cells if their Cl− conductance suffices to
drive Vm to near-saturation. This would result in a fully dominant
effect of the Clcn2op allele with respect to aldosterone secretion,
hypertension, and other parameters. This was clearly not the case
in Clcn2+/op mice. This observation could not be explained by an
intermediate degree of depolarization of Clcn2+/op cells. Sur-
prisingly, about half of Clcn2+/op cells were as strongly depolar-
ized as Clcn2op/op cells (compatible with the notion that
expression from one Clcn2op allele suffices for maximal depo-
larization), whereas the other cells remained hyperpolarized
(Fig. 3d). This finding explains the less pronounced phenotype of
heterozygous mice in a straightforward way. However, the reason
for the apparently bimodal distribution of Vm of Clcn2+/op ZG
cells remains unclear, in particular since ClC-2 appears homo-
geneously expressed in the adrenal cortex. In principle, a bimodal
distribution is compatible with monoallelic expression of Clcn2,
with ~50 % of cells expressing the Clcn2op and the remainder the
WT allele. Monoallelic expression is not rare in mammals52–55
and bioinformatics suggests that Clcn2 might be expressed
monoallelically in some tissues56. We examined this possibility by
staining tissue sections of Clcn2+/− mice for ClC-2. With strict
monoallelic Clcn2 expression a mosaic-like ClC-2 expression
pattern would be expected. However, we failed to find an obvious
difference between Clcn2+/− and WT mice in ClC-2 IHC of
adrenal cortex. We repeated these experiments with colon which
expresses higher levels of ClC-2. Again, no evidence for a mosaic
ClC-2 expression in Clcn2+/− mice was obtained (Supplementary
Fig. 3a). However, we cannot rule out that ClC-2 is expressed at
any given time only predominantly from one allele, in particular
since transcription can occur in stochastic bursts from either
allele54,55. In this scenario, one could imagine that, due to sen-
sitivity and saturation issues, IHC might not strictly correlate
with the more quantitative and sensitive electrophysiology.
Alternatively, one may hypothesize that, as a result from a non-
linear interplay of various ion conductances and intracellular ion
concentration, Vm of ZG cells has two metastable states in the
presence of a medium-sized depolarizing current (such as
potentially expressed from one Clcn2op allele). However, the
fact that also ClC-2 currents of ZG cells appeared bimodally
distributed (Fig. 3c) rather points to an upstream factor con-
trolling the amplitude of these currents. In this respect, it is
important to point out that WT ZG cells, as identified by mor-
phology and Dab2 staining45, express aldosterone synthase
heterogeneously18,45,57–59 (Fig. 5e, Supplementary Fig. 6). The
mechanism for this expression pattern remains enigmatic and it is
unclear whether it relates to the bimodal distribution of Vm in
Clcn2+/op mice.
In any case, ClC-2 currents are unlikely to influence aldoster-
one secretion in WT animals since they are small compared to the
resting K+ conductance of ZG cells22 which drives Vm close to
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the K+ equilibrium potential. This notion is supported by SF1-
Cre; Clcn2op/op mice which lack ClC-2 in ZG cells but display
normal aldosterone.
Clcn2op/op ZG cells depolarized to an average of roughly −40
mV and even reached voltages around −20 mV. If this depolar-
ization is directly caused by a Cl− conductance, intracellular Cl−
concentrations ([Cl−]i) must be at least 30 and 70 mM, respec-
tively, values which can be reached when cells prominently
express a Cl− loader such as NKCC1 (as shown here). A median
value for [Cl−]i ~75 mM has indeed been reported for ZG cells23.
The observed depolarization is amply sufficient to open L- and T-
type Ca2+-channels which we had implicated in Clcn2G24D-
dependent aldosterone secretion in pharmacological experi-
ments22. The resulting increase in [Ca2+]i, as ascertained here, is
a strong trigger for the transcription of aldosterone synthase
(CYP11B2)3.
Although ClC-2 is expressed both in ZG and fasciculata cells,
Clcn2op mice displayed high serum aldosterone, but no increase
in corticosterone levels. Likewise, the patient with the p.Gly24Asp
mutation had normal cortisol levels22. Since the Cl− loader
NKCC1 appears to be expressed in ZG, but not in ZF cells
(Fig. 2d), only ZG cells may display the high intracellular Cl−
concentration required for a depolarizing Cl− efflux and the
subsequent increase of [Ca2+]i. Indeed, measurements with Cl−-
sensitive dyes revealed high [Cl−]i only in the ZG23. Moreover,
unlike aldosterone synthesis, stimulation of corticosterone pro-
duction depends mainly on cAMP rather than on [Ca2+]i2.
While these considerations explain the specific effect of open
ClC-2 channels on aldosterone versus corticosterone secretion,
the wide expression pattern of ClC-2 (ref. 26) suggests that there
may be abnormalities in other cells and tissues of Clcn2op mice.
Though no consistent additional symptoms were reported in
patients with CLCN2-related PA22,23, and although Clcn2op/op
mice appeared grossly normal, it seems worthwhile to investigate
possible effects of constitutively increased plasma membrane Cl−
conductance in other organs. It is important to recall that the
opening of ClC-2 may have divergent effects in different tissues
because [Cl−]i varies widely between cell types. In many cells, like
adrenal ZG cells and most epithelial cells, [Cl−]i is above elec-
trochemical equilibrium. Under these conditions, Cl− channel
opening causes a depolarization and possibly a rise in [Ca2+]i as
found here. In most neurons, however, [Cl−]i is low due to the
presence of the K+Cl−-cotransporter KCC2 (ref. 60) and opening
of Cl− channels entails hyperpolarization that may blunt neu-
ronal excitability. We anticipate to identify additional symptoms
in Clcn2op/op mice that may not only be relevant for basic science
but also for clinical medicine. In any case, Clcn2op mice provide
an excellent mouse model for human PA that will prove useful to
explore its pathophysiology, and possibly therapeutic approaches,
in detail.
Methods
Mice. All animal experiments were approved by the relevant local authorities
(LAGeSo Berlin, Germany) and performed in compliance with the relevant reg-
ulations. If not otherwise stated, all mice were housed under standard conditions
(chow: 0.24% sodium, 0.49% chloride, 0.98% potassium) in the MDC animal
facility according to institutional guidelines. Experiments were performed at dif-
ferent ages (indicated in figure legends) and with both sexes, which were analyzed
separately. Clcn2−/− mice31 and Nkcc1−/− mice61 have been described previously.
To generate Clcn2op/op mice, a 10.6-kb fragment of R1-ES cell genomic DNA
containing exons 1–22 of Clcn2 was cloned into pKO Scrambler Plasmid 901
(Lexicon Genetics Inc.). A neomycin-resistance cassette flanked by FRT sites was
inserted between exons 1 and 2. A deletion of 24 bp (TACACTCAGGAACTCG
GGGCCTTT; aa sequence: YTQELGAF) followed by an additional change of two
amino acids (AK to IS; bp change: GCCAAA to ATATCA) to create an EcoRV site
to aid Southern blot analyses were inserted in exon 2. Additionally two loxP sites
were introduced flanking exons 2 and 3. The linearized vector was electroporated
into R1 ES cells and neomycin-resistant clones were screened by Southern blotting.
Correctly targeted clones were injected into C57BL/6 blastocysts by the MDC
transgenic facility and the resulting chimeric animals were crossed to FLP-deleter
mice62 (in C57BL/6 background) to remove the neomycin-resistance cassette. For
PCR genotyping primers 5´-GAGCGAGGGGTGGGGTCAAAACCC-3´ (P1) and
5´-CTGGATCTTACTGCGACATCTGGC-3´ (P2) were used to detect the
deletion. Clcn2op/op mice were in a C57BL/6-129/Svj mixed genetic background.
Additionally, we crossed Clcn2op/op mice (in which exons 2 and 3 of the Clcn2op
allele are floxed) with SF1-Cre mice46 (The Jackson Laboratory; Tg(Nr5a1-cre)
7Lowl/J that express the recombinase specifically in the adrenal cortex, somatic
gonad cells, pituitary, and SF1-positive neurons in the ventromedial hypothalamic
nucleus.
Antibodies. The rabbit anti-mouse ClC-2 antibody (1:500 for IHC and western
blot (WB)) against a C-terminal peptide of mouse ClC-2 ((C)WGPRSRHGLPR
EGTPSDSDDKSQ) has been described30. Rabbit anti-mouse NKCC1 antibody
(1:250 for IHC) was raised against peptide CDEEEDGKTPTQPLL (coupled to
keyhole limpet hemocyanin via the N-terminal cysteine). It was affinity-purified
against the peptide and KO controls proved its specificity in several tissues. The
following commercial antibodies were used: sheep anti-TGN38 (AHP499, Bio-Rad,
1:200 for IHC), mouse anti β-actin (clone AC-74, Sigma, A2228, 1:1,000 for WB),
sheep anti albumin (Biotrend, 1:5000 for WB), goat anti transferrin (Immunovi-
sion, 1:250 for WB), rabbit anti vitamin D-binding protein (DBP, Bio-Rad, 9580-
2710, 1:300 for WB), rabbit anti Dab2 (1:100 for IHC, sc-13982, Santa Cruz Bio-
technology). Rabbit anti Cyp11b2 (1:25 for IHC) was a generous gift from CE
Gomez-Sanchez (University of Mississippi Medical Center, USA). Rabbit anti-
retinol binding protein (RBP) was a generous gift from Bill Blaner (Columbia
University, NY, USA).
Western blot analyses. For WB analyses of ClC-2 protein in mouse tissue,
membrane fractions were isolated from frozen tissue28. Membrane-containing
pellets were resuspended by sonification in 50 mM Tris pH 6.8, 140 mM NaCl,
0.5 mM EDTA, and 1% SDS and 1% Triton X-100 with protease inhibitors (4 mM
Pefabloc and Complete® EDTA-free protease inhibitor cocktail, Roche). Equal
amounts (10–20 µg) of protein were separated by SDS-PAGE and blotted onto
nitrocellulose. ClC-2 protein bands were quantified using Image Studio Lite Ver
5.2. To collect 24-h urine, mice were housed in metabolic cages (see below). Urine
samples were adjusted to creatinine content and analyzed by western blot for
albumin, transferrin, vitamin D-binding protein (DBP), and retinol-binding
protein (RBP).
Immunohistochemistry. Immunohistochemical staining (IHC) for ClC-2, TGN38,
and NKCC1 was performed on cryosections from adrenal glands of non-perfused
3–12-week-old mice fixed in 1% paraformaldehyde (PFA)/PBS for 1 h at 4 °C, or
from distal colon of mice perfused with 1% PFA/PBS under deep anesthesia. Tissue
was equilibrated in 30% sucrose at 4 °C overnight and cryo-embedded in Tissue
Tek OCT compound (Sakura Finetek). Six micrometer cryosections were prepared
and postfixed with 1% PFA/PBS for 10 min, blocked and permeabilized for 30 min
in 0.25% Triton X-100/5% normal donkey serum (NDS)/PBS. Antibodies were
diluted in 5% NDS/0.1% Tween-20/PBS. Incubation with primary antibody was
performed at 4 °C overnight, and with secondary antibodies (donkey anti-rabbit
Alexa Fluor 488, 1:1000, Thermo Fischer Scientific and donkey anti-sheep
Northern Lights 557, 1:500, R&D Systems) for 1 h at room temperature (RT).
Images were acquired using an LSM880 confocal microscope and ZEN software
and are representative of n ≥ 2 animals analyzed per genotype for each sex.
IHC of Cyp11b2 (aldosterone synthase) and Dab2 protein was performed on
paraffin sections of adrenal glands from 12-week-old mice. Sections were
permeabilized with TBS/0.1% Triton X-100 for 15 min and blocked with 5% BSA/
TBS for Dab2 or with 10% NDS/0.1% Triton X-100/TBS for Cyp11b2. Primary
antibodies were diluted in 3% BSA/TBS for Dab2 or 5% NDS/10% normal rat
serum/0.1% Triton X-100/TBS for Cyp11b2 and incubated for 1 h at RT (Dab2) or
overnight at 4 °C (for Cyp11b2). Primary antibodies were detected with donkey
anti-rabbit Alexa 594 (1/400 for Dab2, 1/500 for mCyp11b2, A21207, Thermo
Fisher). Nuclei were counterstained using 4′,6-diamidino-2-phenylindole (DAPI)
(1/5000, Roche Diagnostics GmbH). Multispectral images were acquired using a
Vectra® automated imaging system and automatically quantified with InForm®
software (both Perkin Elmer). Results of quantification are expressed in percentage
of Cyp11b2- or Dab2-positive ZG cells over total adrenal cortex cells. Statistical
significance was assessed among groups using one-way ANOVA test followed by
Bonferroni’s multiple comparison test.
Histology. To collect adrenal glands for histological analyses, mice were perfused
with 1% PFA/PBS under deep anesthesia or alternatively sacrificed via cervical
dislocation and the organs were postfixed overnight in 1% PFA/PBS.
Haematoxylin–eosin staining was performed with 6 µm sections of paraffin-
embedded organs. ZG area was quantified relative to the whole adrenal gland area
using ImageJ software.
qRT-PCR. For qRT-PCR total RNA from the right adrenal gland of 12-week-old
mice was extracted using the NucleoSpin RNA XS kit (Macherey-Nagel) according
to the manufacturer’s protocol. Frozen tissue was homogenized with a T10 basic
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ultra-turrax (IKA). cDNA was synthesized by reverse transcription from 500 ng of
total RNA using SuperScript II Reverse Transcriptase and random primers (Invi-
trogen). qPCR reactions were prepared using 300 nM primers and Power SYBR
Green PCR Master Mix (Applied Biosystems) and run on a StepOnePlus Real-
Time PCR System (Applied Biosystems). Relative mRNA expression levels of
steroidogenic enzymes (compared to average of Clcn2+/+ animals of same sex)
were calculated using the ΔΔCT method. Normalization involved three reference
genes (mean of Ubiquitin C, ß-actin, and Gapdh expression). Statistical analyses
was performed at the ΔCT stage. The following primers were used:
5′-AGCCCAGTGTTACCACCAAG-3′ and 5′-ACCCAAGAACAAGCACA
AG-3′ for Ubiquitin C;
5′-TGTGATGGTGGGAATGGGTCAGAA-3′ and 5′-TGTGGTGCCAGA
TCTTCTCCATGT-3′ for ß-actin;
5′-AGCCTCGTCCCGTAGACAAAA-3′ and 5′-TGGCAACAATCTCCA
CTTTGC-3′ for Gapdh;
5′-TGTATCGAGAGCTGGCAGAG-3′ and 5′-CCTGGATGGCATCCA
TTGAC-3′ for Cyp11b1;
5′-ACCTACAGTGGCATTGTG-3′ and 5′-GATTGCTGTCGTGTCAAC-3′ for
Cyp11b2;
5′-GTGCTTCATCCACTGGCTGGAA-3′ and 5′-GTCTGCGATAGGACCTG
GTTGA-3′ for Star;
5′-CTTCACGACTGTGTCCAGGACT-3′ and 5′-CCGACTCTCTTGGATCTG
CTTC-3′ for Cyp21a1.
Electrophysiology. TEVC measurements of Xenopus oocytes were performed22.
Mutant channel cDNAs were generated by site-directed mutagenesis and cRNAs
were prepared from pFROG vectors using the mMESSAGE mMACHINE T7 kit
(Ambion) and injected into X. oocytes, at 14 ng per cell for WT ClC-2 (human, rat)
and 9 ng per cell for mutants (human: M22K, G24D, Y26N, R172Q, ΔK362, S865R;
rat: G30D, op). Following 2 days of expression at 17 °C, TEVC was performed at
RT using a TurboTEC amplifier (npi electronic) and pClamp software (Molecular
Devices) to elicit ClC-2 currents (2 s steps from +60 to −120 mV with a final 1 s
step at +40 mV) in ND109 solution containing (in mM) 109 NaCl, 2 KCl, 1 MgCl2,
1.8 CaCl2, and 2 HEPES and adjusted to pH 7.4. To determine the pH sensitivity of
R172Q, currents were first measured in ND109 and again following solution
exchange with ND109 buffered with 5 mM Tris (pH 8.5).
Perforated-patch-clamp analysis of ClC-2 proteins were performed in HEK
cells. Cells were transfected (X-fect) with bicistronic plasmids encoding emGFP (to
identify transfected cells) and, after an IRES sequence, either human WT or mutant
ClC-2 cDNA. Using a Multiclamp 700B amplifier (Axon Instruments), cells were
measured 12–24 h later with amphotericin B-perforated patch clamp. The tips of
patch pipettes were first filled with amphotericin B-free internal pipette solution,
containing (in mM) 110 Cs-methanesulfonate, 30 CsCl, 4 NaCl, 10 HEPES, 1
MgCl2, 1 EGTA (pH 7.4; 290 mOsm/L), and then backfilled with the same solution
containing 200 µg/ml amphotericin B. GFP-expressing cells were selected for
analysis. When adequate access resistance was attained (<30MΩ) a bath solution
containing (in mM) 140 CsCl, 10 HEPES, 1.8 MgCl2, 1.8 CaCl2, and 20 sucrose
(pH 7.4; 300 mOsm/L) was perfused to measure anion currents in the voltage-
clamp configuration (1.5 s 20 mV steps from +40 mV to either −120 mV or −100
mV with a final 1s step at +40mV). Signals were digitized at 10 kHz and filtered at
2 kHz. Measurements were performed at RT (22–24 °C).
For patch-clamp analysis of ZG cells, adrenal slices from 3- to 7-week-old mice
of both sexes were prepared22. Bicarbonate-based bath solutions were used and
continuously bubbled with 95% O2 and 5% CO2. Briefly, adrenal glands were
removed and placed into cold low-Ca2+ solution composed of (in mM) 140 NaCl,
2 KCl, 26 NaHCO3, 10 glucose, 5 MgCl2, and 0.1 CaCl2, pH 7.4. After removal of
surrounding fat tissue, adrenal glands were embedded in 3% low-melting agarose,
sectioned at 70 µm (Leica, VT1200S), and incubated at RT in physiological solution
containing (in mM) 140 NaCl, 2 KCl, 26 NaHCO3, 10 glucose, 2 MgCl2, and 2
CaCl2 and adjusted to pH 7.4. After ≥1 h, slices were transferred to a recording
chamber and imaged with a ×60 objective and DIC optics (Olympus, BX51WI).
Sub-capsular cells were selected for analysis by amphotericin-perforated patch
clamping. Patch pipettes were prepared as described above for analysis of
transfected cells. When the membrane resistance of the perforated cell was stable,
the bath solution was exchanged for continuously 95% O2 and 5% CO2-bubbled
Na+, K+ free solution containing (in mM) 117 NMDG-Cl, 23 NMDG-HCO3,
5 CsCl, 1.3 MgCl2, 9 glucose, and 2 CaCl2, adjusted to pH 7.3. Currents were
elicited using voltage steps from +40 to −100 mV from a holding potential of
−10 mV, with a final 1 s step at +40 mV. For measuring membrane potentials,
gramicidin-perforated patch clamp was used22. Briefly, the tips of patch pipettes
were first filled with solution containing (in mM) 100 KMeSO3, 30 KCl, 4 NaCl,
10 HEPES, 1 MgCl2, 1 EGTA, and 3 MgATP (pH 7.3; 280 mOsm/L), and then
backfilled with the same solution containing 25 µg/ml gramicidin. In all, ~20 min
following tight giga-seal formation, stable membrane potential measurements
(I= 0 configuration) could be measured. Some cells were superfused with
angiotensin II (100nM).
Intracellular Ca2+ measurements. Left adrenal glands from male mice of age 8 to
15 weeks were placed into ice-cold cutting solution containing (in mM) 26
NaHCO3, 125 NaCl, 1.25 NaH2PO4, 10 glucose, 10 HEPES, 3 MgCl2, 0.1 CaCl2, 2.5
KCl. After removal of surrounding fat tissue, adrenal glands were embedded in 3%
low-melting agarose, cut into 250-µm-thick slices using a vibratome (VT 1200 S,
Leica), and loaded with 5 µM Fura-2 AM in the presence of 1× PowerLoadTM (both
Invitrogen) at 37 °C for 30 min. Imaging was performed in recording solution
containing (in mM) 26 NaHCO3, 125 NaCl, 1.25 NaH2PO4, 10 glucose, 10 HEPES,
1 MgCl2, 2 CaCl2, 2.5 KCl. Both solutions were continuously bubbled with 95% O2
and 5% CO2 and pH was adjusted to 7.4. Slices were alternately excited by 340 and
380 nm light using a monochromator (Polychrome V, TILL Photonics). Emission
signals were recorded at 510 nm and images obtained at one frame per second with
a CMOS camera (ORCA-spark, Hamamatsu) on an upright microscope (Axio
Examiner.A1, Zeiss) with a water immersion ×40 objective (W N-Achroplan, Zeiss)
using MetaFluor software (Molecular Devices). Intracellular Ca2+ is represented as
the change in ratio of 340/380 fluorescent signal activity. At the end, some slices
were superfused with angiotensin II (100 nM). For each individual mouse, the
average Ca2+ fluorescence and the percentage of oscillating cells (defined by
amplitudes >0.01 a.u.) were calculated.
Radiotelemetric BP measurement. For these experiments, mice were single
housed. Adult mice (14- to 18-week-old) were anesthetized by inhalation of iso-
flurane (2–2.5 vol%). The radiotelemeters (PA-C40; Data Sciences International)
were implanted subcutaneously, with the sensing tip placed in the aorta via the
right carotid artery. After 10 days of recovery from surgery during which mice were
fed a high-sodium diet (3.23% sodium, 4.90% chloride, 0.97% potassium), BP and
heart rate were recorded for seven consecutive days under the same diet. Subse-
quently mice were kept under three other special diets (low potassium (0.21%
sodium, 0.29% chloride, <0.05% potassium), high potassium (0.21% sodium, 0.29%
chloride, 3% potassium), and control (0.21% sodium, 0.49% chloride, 0.97%
potassium)) for 10 days for acclimatization followed by seven recording days.
Blood and urine analysis. Mice fed with standard diet or special diets (see above)
were anesthetized with 70–150 mg/kg pentobarbital injected intraperitoneally.
Seventy-five microliters of blood was collected via the retro bulbar technique for
analyses of, i.e., electrolytes and pH (iSTAT handheld blood analyzer with EC8+
cartridges, Abbott Laboratories). For hormone measurements blood was collected
from the beating heart of anesthetized mice. After 10–15 min at RT, the blood was
centrifuged at 1600 g and the serum was collected for analysis.
Aldosterone and angiotensin (1–10) quantification was done by Attoquant
Diagnostics GmbH (Vienna, Austria) using a liquid chromatography-mass
spectrometry/mass spectroscopy (LC-MS/MS)-based approach. Murine serum
conditioning for equilibrium analysis was performed at 37 °C followed by
stabilization by addition of an enzyme inhibitor cocktail as described63,64. Previous
results have shown similar qualitative outcomes when comparing the
quantification of circulating and equilibrium angiotensin peptide levels63.
Stabilized equilibrated serum samples and urine samples (see below) were further
spiked with stable isotope-labeled internal standards for each angiotensin
metabolite, angiotensin-(1–10) (Ang I), angiotensin-(1–8) (Ang II), angiotensin-
(2–8) (Ang III), and angiotensin-(3–8) (Ang IV) as well as with deuterated internal
standards for both steroids, aldosterone-D4 and corticosterone-D4, at a
concentration of 200 pg/ml. Following C18-based solid-phase-extraction, samples
were analyzed by liquid chromatography-mass spectrometry/mass spectroscopy
(LC-MS/MS) using a reversed-phase analytical column operating in line with a
Xevo TQ-S triple quadruple mass spectrometer (Waters). Internal standards were
used to correct for peptide and steroid recovery of the sample preparation
procedure for each angiotensin metabolite and steroid in each individual sample.
Analyte concentrations were calculated considering the corresponding response
factors determined in appropriate calibration curves in original sample matrix, on
condition that integrated signals exceeded a signal-to-noise ratio of 10. Renin
activity was calculated as the sum of Ang I and Ang II63,64.
Mice were acclimatized for 10 days to each of the special diets (one group of
mice with control and subsequently with low K+, and another group of mice with
high K+; see above). To collect 24 h urine, mice were housed in metabolic cages
(metabolic cage for single mouse; UNO B.V., Marconistraat 31, 6902 PC Zevenaar,
Netherlands) under the respective special diet. Feces and chow were removed from
the urine. Aldosterone and renin activity was determined by Attoquant Diagnostics
GmbH. Urine was diluted in an Ang I generation buffer containing
ethylenediaminetetraacetic acid (5 µM, Sigma-Aldrich), Z-Pro-Prolinal (20 µM,
Sigma-Aldrich), 4-(2-Aminoethyl)benzenesulfonyl fluoride hydrochloride (1mM,
Sigma-Aldrich), aminopeptidase inhibitor (10 µM, Sigma-Aldrich), and the
substrate murine Angiotensinogen (50 µg/ml, Sino Biological) in phosphate-
buffered saline (Dulbecco’s PBS, pH 7.4, Sigma-Aldrich). Following incubation at
37 °C, the mixture was stabilized and further processed the same as all serum
samples for quantification of angiotensin-(1–10) (Ang I) and aldosterone in LC-
MS/MS analysis. For normalization of the aldosterone concentration in urine and
of urine samples used for western blot analysis, creatinine was measured with an
enzymatic assay (Mouse Creatinine Assay Kit, cat.-no. 80350, Crystal-Chem). The
reaction was quantified by photometric assessment at 550 nm using an xMark
platereader (Bio-Rad).
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Statistics. Data are shown as mean ± SEM, mean ± SD, or geometric mean ±
geometric SD, where n represents the number of animals or cells. Statistical sig-
nificance was assessed between the groups using the Kruskal–Wallis test with
Dunn’s multiple comparison test, Mann–Whitney U test, or one-way-ANOVA
with Bonferroni multiple comparison test, Prism, GraphPad Software, USA).
A p value < 0.05 was considered statistically significant.
Statistical analyses for intracellular Ca2+measurements in Supplementary Fig. 4
were done using “lme4” package (Bates, Maechler & Bolker, 2012) for R to perform
a linear mixed effects analysis of the relationship between Ca2+ fluorescence and
genotype. As fixed effect, we entered genotype into the model; as random effects,
we had intercepts for slice and mouse. The “multcomp” package65 was used for
pairwise comparisons (post-hoc test). This model was used to take into account the
possible effects of the different slices and mice measured.
Reporting Summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The source data underlying Fig. 2a, Supplementary Fig. 2b–d, Supplementary Fig. 10,
Table 1 and Supplementary Table 1 are provided as Source Data file. All other data that
support the findings of this study are available from the corresponding author upon
reasonable request.
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